Literature DB >> 28873140

Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014.

Michihiko Goto1,2, Marin L Schweizer1,2, Mary S Vaughan-Sarrazin1,2, Eli N Perencevich1,2, Daniel J Livorsi1,2, Daniel J Diekema2, Kelly K Richardson1, Brice F Beck1, Bruce Alexander1, Michael E Ohl1,2.   

Abstract

Importance: Staphylococcus aureus bacteremia is common and frequently associated with poor outcomes. Evidence indicates that specific care processes are associated with improved outcomes for patients with S aureus bacteremia, including appropriate antibiotic prescribing, use of echocardiography to identify endocarditis, and consultation with infectious diseases (ID) specialists. Whether use of these care processes has increased in routine care for S aureus bacteremia or whether use of these processes has led to large-scale improvements in survival is unknown. Objective: To examine the association of evidence-based care processes in routine care for S aureus bacteremia with mortality. Design, Setting, and Participants: This retrospective observational cohort study examined all patients admitted to Veterans Health Administration (VHA) acute care hospitals who had a first episode of S aureus bacteremia from January 1, 2003, through December 31, 2014. Exposures: Use of appropriate antibiotic therapy, echocardiography, and ID consultation. Main Outcomes and Measures: Thirty-day all-cause mortality.
Results: Analyses included 36 868 patients in 124 hospitals (mean [SD] age, 66.4 [12.5] years; 36 036 [97.7%] male), including 19 325 (52.4%) with infection due to methicillin-resistant S aureus and 17 543 (47.6%) with infection due to methicillin-susceptible S aureus. Risk-adjusted mortality decreased from 23.5% (95% CI, 23.3%-23.8%) in 2003 to 18.2% (95% CI, 17.9%-18.5%) in 2014. Rates of appropriate antibiotic prescribing increased from 2467 (66.4%) to 1991 (78.9%), echocardiography from 1256 (33.8%) to 1837 (72.8%), and ID consultation from 1390 (37.4%) to 1717 (68.0%). After adjustment for patient characteristics, cohort year, and other care processes, receipt of care processes was associated with lower mortality, with adjusted odds ratios of 0.74 (95% CI, 0.68-0.79) for appropriate antibiotics, 0.73 (95% CI, 0.68-0.78) for echocardiography, and 0.61 (95% CI, 0.56-0.65) for ID consultation. Mortality decreased progressively as the number of care processes that a patient received increased (adjusted odds ratio for all 3 processes compared with none, 0.33; 95% CI, 0.30-0.36). An estimated 57.3% (95% CI, 48.4%-69.9%) of the decrease in mortality between 2003 and 2014 could be attributed to increased use of these evidence-based care processes. Conclusions and Relevance: Mortality associated with S aureus bacteremia decreased significantly in VHA hospitals, and a substantial portion of the decreasing mortality may have been attributable to increased use of evidence-based care processes. The experience in VHA hospitals demonstrates that increasing application of these care processes may improve survival among patients with S aureus bacteremia in routine health care settings.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28873140      PMCID: PMC5710211          DOI: 10.1001/jamainternmed.2017.3958

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  34 in total

Review 1.  Mediation Analysis: A Practitioner's Guide.

Authors:  Tyler J VanderWeele
Journal:  Annu Rev Public Health       Date:  2015-11-30       Impact factor: 21.981

2.  Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.

Authors:  Jennifer S McDanel; Eli N Perencevich; Daniel J Diekema; Loreen A Herwaldt; Tara C Smith; Elizabeth A Chrischilles; Jeffrey D Dawson; Lan Jiang; Michihiko Goto; Marin L Schweizer
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

Review 3.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

4.  Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia.

Authors:  S Tom; J C Galbraith; L Valiquette; G Jacobsson; P Collignon; H C Schønheyder; M Søgaard; K J Kennedy; J D Knudsen; C Ostergaard; O Lyytikäinen; K B Laupland
Journal:  Clin Microbiol Infect       Date:  2014-02-20       Impact factor: 8.067

5.  Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections.

Authors:  Rajiv Jain; Stephen M Kralovic; Martin E Evans; Meredith Ambrose; Loretta A Simbartl; D Scott Obrosky; Marta L Render; Ron W Freyberg; John A Jernigan; Robert R Muder; LaToya J Miller; Gary A Roselle
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

6.  Mediation Analysis with Multiple Mediators.

Authors:  T J VanderWeele; S Vansteelandt
Journal:  Epidemiol Methods       Date:  2014-01

Review 7.  Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association.

Authors:  Larry M Baddour; Walter R Wilson; Arnold S Bayer; Vance G Fowler; Imad M Tleyjeh; Michael J Rybak; Bruno Barsic; Peter B Lockhart; Michael H Gewitz; Matthew E Levison; Ann F Bolger; James M Steckelberg; Robert S Baltimore; Anne M Fink; Patrick O'Gara; Kathryn A Taubert
Journal:  Circulation       Date:  2015-09-15       Impact factor: 29.690

8.  Prevalence of infective endocarditis in patients with Staphylococcus aureus bacteraemia: the value of screening with echocardiography.

Authors:  Rasmus V Rasmussen; Ulla Høst; Magnus Arpi; Christian Hassager; Helle K Johansen; Eva Korup; Henrik C Schønheyder; Jens Berning; Sabine Gill; Flemming S Rosenvinge; Vance G Fowler; Jacob E Møller; Robert L Skov; Carsten T Larsen; Thomas F Hansen; Shan Mard; Jesper Smit; Paal S Andersen; Niels E Bruun
Journal:  Eur J Echocardiogr       Date:  2011-06

9.  Validity of ICD-9-CM coding for identifying incident methicillin-resistant Staphylococcus aureus (MRSA) infections: is MRSA infection coded as a chronic disease?

Authors:  Marin L Schweizer; Michael R Eber; Ramanan Laxminarayan; Jon P Furuno; Kyle J Popovich; Bala Hota; Michael A Rubin; Eli N Perencevich
Journal:  Infect Control Hosp Epidemiol       Date:  2011-02       Impact factor: 3.254

10.  Predictive performance of comorbidity measures in administrative databases for diabetes cohorts.

Authors:  Lisa M Lix; Jacqueline Quail; Opeyemi Fadahunsi; Gary F Teare
Journal:  BMC Health Serv Res       Date:  2013-08-17       Impact factor: 2.655

View more
  25 in total

1.  Effect of Algorithm-Based Therapy vs Usual Care on Clinical Success and Serious Adverse Events in Patients with Staphylococcal Bacteremia: A Randomized Clinical Trial.

Authors:  Thomas L Holland; Issam Raad; Helen W Boucher; Deverick J Anderson; Sara E Cosgrove; P Suzanne Aycock; John W Baddley; Anne-Marie Chaftari; Shein-Chung Chow; Vivian H Chu; Manuela Carugati; Paul Cook; G Ralph Corey; Anna Lisa Crowley; Jennifer Daly; Jiezhun Gu; Ray Hachem; James Horton; Timothy C Jenkins; Donald Levine; Jose M Miro; Juan M Pericas; Paul Riska; Zachary Rubin; Mark E Rupp; John Schrank; Matthew Sims; Dannah Wray; Marcus Zervos; Vance G Fowler
Journal:  JAMA       Date:  2018-09-25       Impact factor: 56.272

Review 2.  Evaluation and management of Staphylococcus aureus bacteriuria: an updated review.

Authors:  Stamatis Karakonstantis; Dimitra Kalemaki
Journal:  Infection       Date:  2017-11-11       Impact factor: 3.553

3.  Clinical variation in the use of echocardiography in Staphylococcus aureus bacteraemia: a multi-centre cohort study.

Authors:  George S Heriot; Steven Y C Tong; Allen C Cheng; Irani Thevarajan; Michele R Levinson; Kumar Visvanathan; Danny Liew
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-22       Impact factor: 3.267

4.  Infectious disease services: a survey from four university hospitals in Germany.

Authors:  Siegbert Rieg; Florian Hitzenbichler; Stefan Hagel; Isabelle Suarez; Florian Kron; Bernd Salzberger; Mathias Pletz; Winfried V Kern; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2018-08-17       Impact factor: 3.553

5.  The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate.

Authors:  Kenton J Johnston; Kenneth E Thorpe; Jesse T Jacob; David J Murphy
Journal:  Health Serv Res       Date:  2019-03-12       Impact factor: 3.402

6.  The epidemiology of hospital-acquired urinary tract-related bloodstream infection in veterans.

Authors:  Payal K Patel; M Todd Greene; Mary A M Rogers; David Ratz; Latoya Kuhn; Jennifer Davis; Sanjay Saint
Journal:  Am J Infect Control       Date:  2018-03-13       Impact factor: 2.918

Review 7.  Antimicrobial Treatment Duration in Sepsis and Serious Infections.

Authors:  Lindsay M Busch; Sameer S Kadri
Journal:  J Infect Dis       Date:  2020-07-21       Impact factor: 5.226

8.  Comparative Effectiveness of Switching to Daptomycin Versus Remaining on Vancomycin Among Patients With Methicillin-resistant Staphylococcus aureus (MRSA) Bloodstream Infections.

Authors:  Marin L Schweizer; Kelly Richardson; Mary S Vaughan Sarrazin; Michihiko Goto; Daniel J Livorsi; Rajeshwari Nair; Bruce Alexander; Brice F Beck; Michael P Jones; Mireia Puig-Asensio; Daniel Suh; Madeline Ohl; Eli N Perencevich
Journal:  Clin Infect Dis       Date:  2021-01-29       Impact factor: 9.079

9.  The Current State of Antifungal Stewardship in Immunocompromised Populations.

Authors:  William Alegria; Payal K Patel
Journal:  J Fungi (Basel)       Date:  2021-04-30

10.  Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study.

Authors:  Carlos Mejia-Chew; Jane A O'Halloran; Margaret A Olsen; Dustin Stwalley; Ryan Kronen; Charlotte Lin; Ana S Salazar; Lindsey Larson; Kevin Hsueh; William G Powderly; Andrej Spec
Journal:  Lancet Infect Dis       Date:  2019-09-24       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.